Brown Advisory Inc. bought a new stake in Ingevity Corp (NASDAQ:NGVT) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 12,789 shares of the company’s stock, valued at approximately $436,000.
A number of other institutional investors have also added to or reduced their stakes in NGVT. LSV Asset Management acquired a new position in Ingevity Corp during the second quarter valued at about $3,238,000. GMT Capital Corp purchased a new stake in Ingevity Corp during the second quarter worth $4,417,000. Alpha Omega Wealth Management LLC purchased a new stake in Ingevity Corp during the second quarter worth $301,000. Zevin Asset Management LLC purchased a new stake in Ingevity Corp during the second quarter worth $368,000. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new stake in Ingevity Corp during the second quarter worth $512,000.
Ingevity Corp (NASDAQ:NGVT) traded down 1.67% during midday trading on Monday, reaching $45.33. The company had a trading volume of 173,240 shares. The company has a market capitalization of $1.91 billion and a P/E ratio of 30.30. The company’s 50 day moving average is $44.73 and its 200-day moving average is $38.60. Ingevity Corp has a 52-week low of $23.00 and a 52-week high of $48.30.
Ingevity Corp (NASDAQ:NGVT) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.15. Equities analysts expect that Ingevity Corp will post $1.94 earnings per share for the current fiscal year.
A number of equities research analysts recently weighed in on the company. SunTrust Banks Inc. restated a “buy” rating on shares of Ingevity Corp in a report on Saturday, August 6th. Buckingham Research assumed coverage on Ingevity Corp in a report on Friday, September 23rd. They issued a “neutral” rating on the stock. Jefferies Group assumed coverage on Ingevity Corp in a report on Friday, September 23rd. They issued a “buy” rating and a $57.00 price target on the stock. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $50.00 price target (up previously from $44.00) on shares of Ingevity Corp in a report on Wednesday, September 7th. Finally, KeyCorp assumed coverage on Ingevity Corp in a report on Thursday, July 7th. They issued an “overweight” rating and a $43.00 price target on the stock. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $48.60.
Ingevity Corp Company Profile
Ingevity Corporation is a manufacturer of specialty chemicals, carbon materials and technologies. The Company operates through two segments: Performance Materials and Performance Chemicals. The Company’s specialty chemicals products serve as inputs used in a range of high performance applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants and printing inks.
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NASDAQ:NGVT).
Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.